Aperio Clinical Outcomes Revenue, Growth & Competitor Profile

DBA INNO CLINICAL OUTCOMES, LLC

Company Profile & Annual Report for Aperio Clinical Outcomes

Access the complete profile.

Aperio Clinical Outcomes Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	621511 Medical Laboratories
Additional NAICS Codes	5417 Scientific Research & Development Services
Address	318 Blackwell Street Suite 120 Durham, NC 27701

Note: Revenues for privately held companies are statistical evaluations.


Aperio Clinical Outcomes's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Aperio Clinical Outcomes's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Aperio Clinical Outcomes is classified as operating in the Medical Laboratories industry, NAICS Code 621511.

Aperio Clinical Outcomes Annual Revenue and Growth Rate

Aperio Clinical Outcomes	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Aperio Clinical Outcomes's revenues are gauged from an analysis of company filings.

Aperio Clinical Outcomes's Income Statement (based on Industry Averages)

Aperio Clinical Outcomes P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Aperio Clinical Outcomes is developing and marketing. Aperio Clinical Outcomes doesn't have any recent trademark applications, indicating Aperio Clinical Outcomes is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
APERIO CLINICAL OUTCOMES Contract research organization (CRO) services, namely, conducting clinical trials for others; Contract research organization (CRO) services, namely, monitoring of clinical trials for investigational drugs of biotech and pharmaceutical companies for others, clinical trial project management and quality assurance for others, medical writing of investigational drug protocols and clinical study reports for others, data management and electronic data capture (EDC) database programming of clinical trials and biostatistical analysis for others; Consulting services in the field of conducting clinical trials in the pharmaceutical industry, the biotechnology industry and the medical device and diagnostics industries; Providing quality assurance services in the field of regulatory submissions to the FDA by life sciences companies to ensure validity and accuracy for others; Providing quality assurance services in the medical, pharmaceutical, biotechnology and medical device fields for others	05/20/2019
A APERIO CLINICAL OUTCOMES WE MAKE IT CLEAR Contract research organization (CRO) services, namely, conducting clinical trials for others; Contract research organization (CRO) services, namely, monitoring of clinical trials for investigational drugs of biotech and pharmaceutical companies for others, clinical trial project management and quality assurance for others, medical writing of investigational drug protocols and clinical study reports for others, data management and electronic data capture (EDC) database programming of clinical trial and biostatistical analysis for others; Consulting services in the field of conducting clinical trials in the pharmaceutical industry, the biotechnology industry and the medical device and diagnostics industries; Providing quality assurance services in the field of regulatory submissions to the FDA by life sciences companies to ensure validity and accuracy for others; Providing quality assurance services in the medical, pharmaceutical, biotechnology and medical device fields for others	08/28/2017

See all trademarks and details in the Full Report.

Market Share of Aperio Clinical Outcomes's Largest Competitors

A competitive analysis shows these companies are in the same general field as Aperio Clinical Outcomes, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
PHYSICIANS IMMUNODIAGNOSTIC LABORATORY	Burbank, CA	100
ACCU REFERENCE MEDICAL LAB LIMITED LIABILITY	Linden, NJ	100
CENTOGENE US	Cambridge, MA	88
LATARA ENTERPRISE	Pomona, CA	61
TELIGENT PHARMA	Vineland, NJ	46
COVID CLINIC	Huntington Beach, CA	37
VIKOR SCIENTIFIC	Charleston, SC	33
BIOTHERANOSTICS	San Diego, CA	31
SHERMAN-ABRAMS LABORATORY	Brooklyn, NY	31

Nearby Competitors

These companies are similar in business line and location to Aperio Clinical Outcomes. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
APERIO CLINICAL OUTCOMES	Durham, NC	100
VERASCI	Durham, NC	60
VERO DIAGNOSTICS	Durham, NC	36
HEART IMAGING TECHNOLOGIES	Durham, NC	14
TRYTON MEDICAL	Durham, NC	12
KB RESOURCES	Durham, NC	8

Other Companies at 318 Blackwell Street, Durham NC

Company	Headquarters	Revenue ($ MM)
MCKINNEY VENTURES	Durham, NC	100
PALLET ALLIANCE	Durham, NC	22
ME FINE FOUNDATION	Durham, NC	4

Future Competition: Aperio Clinical Outcomes's Fastest Growing Competitors

These companies are in the same general field as Aperio Clinical Outcomes and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)